We hypothesize that blockade of IRE1 signaling will preserve the oncologic efficacy of chemotherapy while preventing chemotherapy‐related cardiac toxicity in TNBC preclinical breast cancer models in the context of obesity. This evidence concerns the gene ERN1 and breast cancer.